September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
The outcome of Endoscopic Cyclophotocoagulation (ECP) combined with Phacoemulsification in Pseudoexfoliation (PXFG) compared to Primary Open Angle Glaucoma (POAG)
Author Affiliations & Notes
  • Leyla Ali Aljasim
    Glaucoma, KKESH, Riyadh, Saudi Arabia
  • Ohoud Owaydhah
    Glaucoma, KKESH, Riyadh, Saudi Arabia
  • Footnotes
    Commercial Relationships   Leyla Ali Aljasim, None; Ohoud Owaydhah, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 6473. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Leyla Ali Aljasim, Ohoud Owaydhah; The outcome of Endoscopic Cyclophotocoagulation (ECP) combined with Phacoemulsification in Pseudoexfoliation (PXFG) compared to Primary Open Angle Glaucoma (POAG). Invest. Ophthalmol. Vis. Sci. 2016;57(12):6473.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The presence of exfoliation (in PXFG) makes it difficult to achieve coagulation of ciliary processes with ECP, the end result of ECP treatment is shrinkage of ciliary processes that result in Aqouas production reduction, which can be measured through post oprative reduction in IOP and glaucoma medication. The efficacy of ECP in PXFG will be measured through comapring IOP and glaucoma medication reduction following ECP combined with phaco with eyes with POAG.

Methods : Retrospective Cohort study; file review of PXFG & POAG (controlled or uncontrolled IOP, with and without glaucoma medications) underwent phaco+ECP & followed up ≥ 6month. Eyes were virgin & laser naïve.

Results : 56 PXFG eyes & 72 POAG, with baseline IOP 18.5±6 & 16.7±4 mmHg(P=0.03), on 2.3±1 & 3±2 medication(P=0.04) respectively
mostly had 180°ECP, with 0.27W PXFG & 0.25W POAG(P=0.05)
Mean follow up 15±10 & 17±14months
Last visit IOP 14.8±4mmHg PXFG & 15.3±4 POAG, on1.5±1 & 1.6±1 medication (P=0.5,P=0.74);
IOP reduced by 3.7±7 & 1.4±4mmHg & medication by 0.7±1.5 & 1.3±2.5 respectively(P=0.02, P=0.15)
3 eyes with PXFG needed 2nd procedure to control IOP

Conclusions : ECP has favorable effect in PXFG compared to POAG

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×